ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
US Tech 100
19,878.40
0.16%
Dow Jones
40,211.72
0.53%
Brent Oil
83.54
-0.95%
Bitcoin
63,486.86
-2.10%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. IN8bio Inc (INAB)

  7. IN8bio Inc (INAB) News

INAB

IN8bio (INAB)

IN8bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INAB
DateTimeSourceHeadlineSymbolCompany
11/09/20234:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
11/09/20234:00PMGlobeNewswire Inc.IN8bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:INABIN8bio Inc
11/06/20238:00AMGlobeNewswire Inc.IN8bio Presents Biologic Correlative Data from the INB-200 Phase 1 Trial in Newly Diagnosed Glioblastoma at the Society for Immunotherapy of Cancer (SITC) 38th Annual MeetingNASDAQ:INABIN8bio Inc
11/03/202312:00PMGlobeNewswire Inc.IN8bio Presents Positive Data Update from Induced Pluripotent Stem Cell (iPSC) Platform at the Society for Immunotherapy of Cancer (SITC) 38th Annual MeetingNASDAQ:INABIN8bio Inc
11/02/20239:17AMGlobeNewswire Inc.IN8bio to Present New Positive Data from Phase 1 Trial of INB-100 at 2023 American Society of Hematology (ASH) Annual MeetingNASDAQ:INABIN8bio Inc
11/01/20238:00AMGlobeNewswire Inc.IN8bio to Participate at the 2023 Truist Securities BioPharma SymposiumNASDAQ:INABIN8bio Inc
10/12/20238:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
10/12/20238:00AMGlobeNewswire Inc.IN8bio Completes Dose Escalation in Phase 1 Trial of INB-100, a Potential First-in-Class Gamma-Delta T Cell Therapy for the Treatment of Leukemias, and Initiates Enrollment for the Phase 2 Trial of INB-400 in Newly Diagnosed GlioblastomaNASDAQ:INABIN8bio Inc
09/29/20238:00AMGlobeNewswire Inc.IN8bio Announces Presentations at the Society for Immunology of Cancer (SITC) 38th Annual MeetingNASDAQ:INABIN8bio Inc
09/26/20238:00AMGlobeNewswire Inc.IN8bio to Host Research & Development Day on its Gamma-Delta T cell Therapies on Thursday, October 12, 2023 in New York CityNASDAQ:INABIN8bio Inc
09/20/20238:00AMGlobeNewswire Inc.IN8bio to Participate at the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:INABIN8bio Inc
09/19/20238:03AMGlobeNewswire Inc.IN8bio Strengthens Intellectual Property Portfolio with Newly Granted Global PatentsNASDAQ:INABIN8bio Inc
09/15/20234:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
09/06/20238:00AMGlobeNewswire Inc.IN8bio to Participate at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:INABIN8bio Inc
08/28/20234:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
08/28/20234:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INABIN8bio Inc
08/18/20235:09PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INABIN8bio Inc
08/18/20235:07PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:INABIN8bio Inc
08/18/20235:02PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:INABIN8bio Inc
08/15/20238:00AMGlobeNewswire Inc.IN8bio to Present at the H.C. Wainwright Immune Cell Engager Virtual ConferenceNASDAQ:INABIN8bio Inc
08/11/20234:28PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:INABIN8bio Inc
08/11/20234:18PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:INABIN8bio Inc
08/10/20235:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INABIN8bio Inc
08/10/20235:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INABIN8bio Inc
08/10/20234:15PMGlobeNewswire Inc.IN8bio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:INABIN8bio Inc
08/08/20238:00AMGlobeNewswire Inc.IN8bio Expands Capabilities with the Grand Opening of its Advanced Research and Development FacilityNASDAQ:INABIN8bio Inc
07/31/20234:42PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INABIN8bio Inc
07/14/20235:28PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INABIN8bio Inc
06/23/20236:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
06/23/20236:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INABIN8bio Inc
 Showing the most relevant articles for your search:NASDAQ:INAB

Your Recent History

BIT
1GME
Gamestop
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved